Retatrutide 10mg is a next-generation triple agonist peptide that targets GLP-1, GIP, and glucagon receptors to deliver superior metabolic support. With clinical studies showing up to 24.2% body weight reduction in 48 weeks, this higher-strength formula enhances fat burning, appetite control, and energy regulation. Ideal for those seeking advanced solutions in weight management, Retatrutide 10mg offers powerful results in the fight against obesity and metabolic disorders.
| weight | 10mg |
|---|---|
| Subsciption | Get 7% off monthly |
71 in stock
Higher-Dose Formula – Enhanced 10mg concentration for maximum therapeutic impact.
Triple Action Mechanism – Activates GLP-1, GIP, and glucagon receptors simultaneously.
Clinically Supported Weight Loss – May help reduce body weight by over 24% in 48 weeks.
Improved Satiety & Appetite Control – Naturally reduces hunger and increases fullness.
Metabolic Health Support – Boosts fat metabolism and supports healthy glucose levels.
All products offered on this website are strictly intended for research and development purposes only. They are not for human consumption in any form.
The statements presented on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). Neither the statements nor the products offered by this company are intended to diagnose, treat, cure, or prevent any disease.
Superhuman Peptides operates solely as a chemical supplier. It is not a compounding pharmacy or a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Superhuman Peptides is also not an outsourcing facility as defined under Section 503B of the same Act.
This website contains information about supplementary products. By entering, you confirm that you are of legal age (18 years or older) to access this information. If you are not of legal age, please leave this site immediately.
